COO Kasper Jakobsen selected as CEO-elect and appointed to Board of
Directors
GLENVIEW, Ill.--(BUSINESS WIRE)--Jun. 15, 2012--
Mead Johnson Nutrition Company (NYSE: MJN) announced today that its
President and Chief Executive Officer, Steve Golsby, notified the Board
of Directors of his intent to retire by the 2013 annual meeting of
stockholders. Mr. Golsby informed the Board of his intentions at the
Company’s Board meeting and pledged his commitment to support the
succession plan in the months ahead.
Subsequently, the Board of Directors unanimously selected Kasper
Jakobsen, currently Executive Vice President and Chief Operating Officer
of Mead Johnson Nutrition, as CEO-elect and appointed him to the MJN
Board of Directors effective immediately. Mr. Jakobsen is expected to
succeed Mr. Golsby as Mead Johnson Nutrition President and CEO upon Mr.
Golsby’s retirement. Kasper Jakobsen will continue in his role as Chief
Operating Officer, and the current senior leadership structure and
reporting relationships will remain in effect.
Chairman of the Board Jim Cornelius stated that, “Steve has been an
extraordinary leader of the Mead Johnson Nutrition team since the
Company’s initial public offering (IPO) on the New York Stock Exchange
in February 2009, and for many years prior to that, while MJN was a
wholly owned subsidiary of Bristol-Myers Squibb. The Board is fully
supportive of Mr. Golsby continuing to serve as a director on the MJN
Board following his retirement. The Board maintains robust succession
plans at all senior levels of the organization contemplating such
events. As Steve’s replacement, Kasper Jakobsen has the confidence of
the full Board, reflecting his experience as a 14-year veteran of Mead
Johnson, including operational leadership responsibility for the
businesses in Asia, North America and Latin America prior to becoming
Executive Vice President and Chief Operating Officer earlier this year.”
Commenting on his planned retirement, Mr. Golsby thanked the Board for
the strong support and insightful guidance it has given him during his
tenure as CEO, saying, “I feel privileged to have led Mead Johnson for
over eight years and to have had the opportunity to manage its
transformation into a high-performing public company and a global leader
in its category. I know I will be leaving the Company in good hands,
with an outstanding Board and talented global management team who can
build upon the success we have achieved to date, and I look forward to
having the opportunity to serve on the Mead Johnson Board following my
retirement as CEO.”
About Mead Johnson
Mead Johnson, a global leader in pediatric nutrition, develops,
manufactures, markets and distributes more than 70 products in over 50
markets worldwide. The company's mission is to nourish the world's
children for the best start in life. The Mead Johnson name has been
associated with science-based pediatric nutrition products for over 100
years. The company's "Enfa" family of brands, including Enfamil(R)
infant formula, is the world's leading brand franchise in pediatric
nutrition.
For more information on the company, go to meadjohnson.com.
Source: Mead Johnson Nutrition Company
Mead Johnson Nutrition Company
Media:
Christopher
Perille, (847) 832-2178
chris.perille@mjn.com
or
Investors:
Kathy
MacDonald, (847) 832-2182
kathy.macdonald@mjn.com